Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBF.10EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CT.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.10.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FF.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DN.1.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.75.9EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBHEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.78EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.9.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.64EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBC.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.221.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
DP.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BL.1.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.62EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.82EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.20EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.3.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.38.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.2.79.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.47EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BF.7.18EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XAY.1.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BQ.1.1.55EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BY.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XJEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BR.5EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.8EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.1.29EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.5.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CM.8.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBSEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.99EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBF.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.343EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.4.17 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AY.25.1.2 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.409EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.310EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.362.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.162EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Y.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.86EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.154EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used